about
Dietary factors, hormesis and healthComplementary and Alternative Therapies in Amyotrophic Lateral SclerosisCaloric restriction shortens lifespan through an increase in lipid peroxidation, inflammation and apoptosis in the G93A mouse, an animal model of ALS.The effect of diet on the protective action of D156844 observed in spinal muscular atrophy mice.One universal common endpoint in mouse models of amyotrophic lateral sclerosis.Genetically altering organismal metabolism by leptin-deficiency benefits a mouse model of amyotrophic lateral sclerosisBody mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosisHypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trialDihydrotestosterone ameliorates degeneration in muscle, axons and motoneurons and improves motor function in amyotrophic lateral sclerosis model mice.Fasting: molecular mechanisms and clinical applications.Cholesterol, oxysterol, triglyceride, and coenzyme Q homeostasis in ALS. Evidence against the hypothesis that elevated 27-hydroxycholesterol is a pathogenic factor.Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral SclerosisTrials of antidiabetic drugs in amyotrophic lateral sclerosis: proceed with caution?A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosisIncreased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis.Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort.Skeletal muscle in motor neuron diseases: therapeutic target and delivery route for potential treatments.Reduced energy intake: the secret to a long and healthy life?Reduced activity of AMP-activated protein kinase protects against genetic models of motor neuron disease.Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons.Decline in daily running distance presages disease onset in a mouse model of ALS.A plural role for lipids in motor neuron diseases: energy, signaling and structure.High-fat and ketogenic diets in amyotrophic lateral sclerosis.Ventilatory control in ALS.New therapy options for amyotrophic lateral sclerosis.Mechanisms controlling neuromuscular junction stability.The interplay between metabolic homeostasis and neurodegeneration: insights into the neurometabolic nature of amyotrophic lateral sclerosis.The Role of Skeletal Muscle in Amyotrophic Lateral Sclerosis.Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic TreatmentsEnergy Homeostasis and Abnormal RNA Metabolism in Amyotrophic Lateral SclerosisALS disease onset may occur later in patients with pre-morbid diabetes mellitus.Body mass index (BMI) as predictor of ALSFRS-R score decline in ALS patients.Respiratory and nutritional support in amyotrophic lateral sclerosis.Neuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and Disease.Synaptic Failure: Focus in an Integrative View of ALS.
P2860
Q24644082-5FB63876-923D-4F8D-815E-EAACF926C35DQ26777929-CFFB7F09-FE61-47E3-8089-F0143514FEAFQ33535799-1C4341DA-1405-44BE-A3D1-9364029B4077Q33645966-A3F273C7-1266-4F81-BAA2-4621A0777E4EQ33936763-4DC97DA2-DDC1-471C-A9E5-EFBD908FB543Q34074537-3A6EE7A2-EEF5-456C-8324-386D5C7E1085Q34187004-CDF46E84-6CA6-49ED-B002-1D830B03E10AQ34251334-B9D0DC92-DDE6-4021-B032-C55883958C60Q34273954-D820460B-26D6-419E-811E-BE7B376BB831Q34398790-686954A2-8650-4D79-B724-BA8761AB2638Q34557247-94F79826-4A9B-427D-BFF1-3D8AEFC4CB57Q34797530-8CBB09C2-D176-4D96-B0F8-49AC0B4CFA5DQ35618724-2129ADF8-63F2-4FDB-BCAC-99EB499EEC9DQ35822554-3D5B0D44-EEFA-4BD4-97D9-9E52998E2F0BQ35987553-F91A78A3-D714-4AA5-90FB-FEBD51A4FCE9Q36687156-A8723E04-B50F-46D7-A489-F76C4F6A12A8Q36805205-5696C1B6-2D99-436D-A2EF-3C0AC08FD31CQ36959217-02309523-6758-4B71-B12C-09C88FC7E6A7Q37093737-07C0BFDD-2E71-4FD9-8D60-52848D1EEDB8Q37165781-62FDEE4F-DF99-49A9-B145-5C6062020AC6Q37251795-C66DB6D8-AD10-4C5E-AE64-100CB5C213AAQ37594297-18259B27-B525-4C50-BB24-B839DD09D496Q38105917-5639F762-1AD0-40B2-B113-5F45B6A2565DQ38108422-475508BD-0695-4A19-A1BD-97A6811C2033Q38121637-B5BF3CEE-5BB3-44FF-95D5-55315D94CFD6Q38264058-CDF5C608-37BA-4C13-9905-63607BA8F5E2Q38577066-6942191F-630A-40AA-89CC-CB197AD28FD0Q38701055-D7D5F83D-BFD2-4C3B-9916-3CF87D3694C1Q39101800-EF59548C-B8BF-46DD-B04A-D85761567A77Q39316849-5BAC77C3-45A7-444A-8111-1E05C8207897Q43504933-C7457BC7-2040-4AF0-B1DD-A324F701640FQ44276835-EC62578E-5AC3-4920-A113-B024F65DC47BQ46636879-329CAF8A-6A97-4E35-8B4E-95690D028F22Q49334640-C8BBA681-4B2E-40AF-80F9-CAA7E6741407Q55233896-747BA607-FDE9-4BF3-89AF-D4674BC50193
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Energy intake and amyotrophic lateral sclerosis.
@ast
Energy intake and amyotrophic lateral sclerosis.
@en
Energy intake and amyotrophic lateral sclerosis.
@nl
type
label
Energy intake and amyotrophic lateral sclerosis.
@ast
Energy intake and amyotrophic lateral sclerosis.
@en
Energy intake and amyotrophic lateral sclerosis.
@nl
prefLabel
Energy intake and amyotrophic lateral sclerosis.
@ast
Energy intake and amyotrophic lateral sclerosis.
@en
Energy intake and amyotrophic lateral sclerosis.
@nl
P356
P1476
Energy intake and amyotrophic lateral sclerosis.
@en
P2093
Roy G Cutler
P2888
P356
10.1385/NMM:9:1:17
P577
2007-01-01T00:00:00Z
P6179
1018298120